CHAMGAP
APPROVEDReviewed and approved by the Chamgap Editorial Team (2026-08-04). The draft was written by AI, the existence of all 2 cited sources was verified at the original page, and the verdict passed blind grading and adversarial audit. Methodology v0.6.
Verdict No. 2167 · Search date 2026-08-04 · Methodology v0.6

Tomato sauce plus olive oil,
does it really help with Six-hour changes in leukocyte adhesion molecules and circulating inflammatory markers?

30-Second Summary
C
Evidence Grade C · 48 · Safety acceptable
Olive-oil tomato sauce changed some postprandial inflammatory and adhesion markers, but the registered marker family was not uniformly positive
Tomato sauce and olive oil are generally safe in ordinary food portions. People with reflux symptoms or tomato allergy may need to individualize intake.
What the
research shows
The grade is C with 48 points. In a randomized crossover study of forty healthy adults, tomato sauce with refined olive oil produced favorable six-hour changes in LFA-1, CD36, IL-6, and VCAM-1 versus raw tomato or oil-free sauce, but several registered adhesion markers, including Mac-1, did not differ. This was a one-meal laboratory study, not a trial of myocardial infarction or stroke.
What the
ads claim
The claim of stronger cardiovascular protection rests on selected six-hour markers. It is not long-term prevention and cannot be assigned solely to olive oil.
*

Useful facts when choosing a product

  • The sauce contained 5% refined olive oil; equal water was added to the oil-free sauce to match tomato concentration.
  • For a 70-kg participant, the serving was about 245 g sauce and 12.25 g refined olive oil.
  • LFA-1 changed -9.6 arbitrary units with the oil sauce, while several registered markers including Mac-1 did not differ.
  • The endpoint was a six-hour laboratory response, not cardiovascular events or long-term vascular function.
Gap Measurement · Verdict 2167 · C 48
What advertising claims
What independent, higher-quality research supports
△ GAP
01

What the research actually shows

Forty participants received raw tomato 7.0 g/kg, oil-free tomato sauce 3.5 g/kg, tomato sauce with 5% refined olive oil 3.5 g/kg, and sugar-water control in randomized order one month apart. There was no olive-oil-only arm. ISRCTN20409295 registered leukocyte adhesion-molecule expression, including LFA-1, CD40L, Mac-1, Sialyl-Lewis, and VLA-4, as primary outcomes. LFA-1 changed -9.6 arbitrary units, 95% CI -17.0 to -2.2, with oil-enriched sauce versus +1.6, -7.7 to 10.8, with oil-free sauce; Mac-1 had P=0.814. The study did not directly measure absorption AUC, peak concentration, or fractional absorption; it measured six-hour adhesion and inflammatory markers. More absorption or a better marker is a different question from better health, and no trial was identified that measured long-term myocardial infarction or stroke outcomes for this exact pairing.

02

Why this is classified as C (48)

Some registered adhesion and inflammatory markers favored the intervention, but others were null in a forty-person one-meal surrogate study, giving C with 48 points.

Counterpoint. The finished sauce produced a real acute signal, while long-term prevention and ingredient-specific attribution remain separate questions.

Rejudgment record. Cross-check applied — The multiple primary adhesion markers in ISRCTN20409295 were checked against the source tables, separating the combined food's acute markers from clinical events

Scoring profile behind this grade
EndpointSSurrogate marker - laboratory or imaging measures
ReplicationR1Single confirmatory trial
IndependenceI2Decisive evidence is publicly or non-profit funded
Effect sizeE~Statistically positive but below the threshold

The scoring table and the verdict agree (C).

Sub-claim grades by effect

This ingredient is marketed for several effects. A single overall grade blends strong and weak claims together, so each effect is graded separately here. The overall grade reflects the strongest disconfirming or core claim.

Effect (sub-claim)GradeBasis
Improved six-hour adhesion and inflammatory markersCSome markers were positive, but the registered marker family was not uniformly positive.
Prevention of myocardial infarction or stroke?Clinical events were not measured for this exact food pairing.

Cross-check — Codex and Claude

This verdict was drafted by Codex through literature review and source-existence checks, cross-checked through blind grading and adversarial audit, and settled by reapplying the methodology boundary rules. Cases with split grades were resolved through rejudgment.
03

Evidence Table

StudyDesignSampleFundingEndpointResultWeight
Study 1Open randomized four-condition crossover single-meal study40Spanish public grants; refined olive oil donated in kindSix-hour leukocyte adhesion molecules and circulating inflammatory markersSome favorable LFA-1, CD36, IL-6, and VCAM-1 results; several registered markers including Mac-1 were nullCore acute surrogate evidence
§

Receipt — 2 References

All 2 cited sources were verified for existence at the original page (as of 2026-08-04).

Valderas-Martínez P, Chiva-Blanch G, Casas R, et al. Tomato Sauce Enriched with Olive Oil Exerts Greater Effects on Cardiovascular Disease Risk Factors than Raw Tomato and Tomato Sauce: A Randomized Trial. Nutrients. 2016;8(3):170. PMID: 26999197. PMCID: PMC4808898. DOI: 10.3390/nu8030170.
checked
ISRCTN Registry. ISRCTN20409295. Effects of processing of tomato on bioavailability of phenolic compounds and inflammatory biomarkers related to atherosclerosis.
checked
Draft and rewrite: Codex (AI) · Verification: Codex blind grading and adversarial audit · Final adjudication: Claude
Reviewed and approved: Chamgap Editorial Team · Approval date: 2026-08-04 · Corrections: none

Cite this verdict

Tomato sauce plus olive oil x postprandial atherosclerosis-related markers Evidence Grade C card
[Chamgap] Tomato sauce plus olive oil x postprandial atherosclerosis-related markers — Evidence Grade C·48. 2 cited sources checked. Source: https://chamgap.com/en/verdicts/heart/tomato-sauce-refined-olive-oil-postprandial-atherosclerosis-markers/ · CC BY 4.0

CC BY 4.0 — free to use with attribution; do not distort grades, numbers, or verdict meaning.

!

What this document does and does not do

Chamgap is an information source. It reports what research has and has not confirmed; it does not tell readers what to take or buy. That decision belongs to readers and, when needed, medical or legal professionals. This verdict reflects literature available up to the search date and may change as new research appears. Nothing here is medical advice.